PUBLIC COMPANY
saveVIELA BIO
USupdated 5mo ago
community read0 votes
pipeline
0
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(0)
no pipeline products on record
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Amgen asset from $27.8B Horizon buy scores in Phase 3 Sjögren's studyAmgen is awaiting another Phase 3 readout for the investigational Sjögren's disease therapy, set for later this year. William Blair anticipates that at least two trials will be needed to support an…biospace · 10d ago
- Amgen reports a Phase 3 win with Sjögren’s drug candidateDazodalibep, acquired in Amgen’s big buyout of Horizon Therapeutics, succeeded in the first of two late-stage trials against the tough-to-treat autoimmune disorder.biopharma_dive · 11d ago
- Amgen’s Horizon-acquired fusion protein eases Sjögren's severity in ph. 3 winAn investigational drug for the autoimmune condition Sjögren's disease has scored a phase 3 win for Amgen, marking a positive sign for the Horizon Therapeutics-acquired pipeline that has so far str…fiercebiotech · 11d ago
comments(0)
5-min edit window · permanent after that